Home/Filings/4/0001140361-24-008886
4//SEC Filing

Shah Gaurav 4

Accession 0001140361-24-008886

CIK 0001281895other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 8:54 PM ET

Size

11.0 KB

Accession

0001140361-24-008886

Insider Transaction Report

Form 4
Period: 2024-02-16
Shah Gaurav
DirectorCEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-02-16+196,336196,336 total
    Exercise: $30.01Exp: 2034-02-16Common Stock (196,336 underlying)
  • Sale

    Common Stock

    2024-02-16$29.84/sh20,272$604,876554,762 total
  • Award

    Common Stock

    2024-02-16+66,577621,339 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    207,897
  • Common Stock

    (indirect: By Trust)
    198,341
Footnotes (5)
  • [F1]The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the "Lock-Up Agreement").
  • [F2]The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.
  • [F3]The shares of common stock were sold by the Reporting Person pursuant to an exemption to the Lock-Up Agreement in order to pay tax withholding obligations in connection with the vesting of RSUs. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement.
  • [F4]Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years.
  • [F5]This option represents a right to purchase a total of 196,336 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.

Issuer

ROCKET PHARMACEUTICALS, INC.

CIK 0001281895

Entity typeother

Related Parties

1
  • filerCIK 0001725922

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 8:54 PM ET
Size
11.0 KB